Survey of PAP and Paracetamol in Asia Pacific
Driven by the demand from the downstream products especially paracetamol, para-aminophenol (PAP) of China keeps developing in recent years. As the main PAP producer in the world, the output of PAP in China already comes to about 110,000 tonnes in 2010.
China and India, two largest API producers in the world, supply 80% of the global paracetamol market in 2010, leading Asia to be the largest origin of paracetamol. Meanwhile, the huge population makes it the largest consumption market of the world. Asia consumes 65,400 tonnes of paracetamol—half of the global output of 2010, though part of that is exported in the form of formulation. As the economy develops, Asia market will be more important.
We study the six most populous countries of AP including China, India, Indonesia, Bangladesh, Pakistan and Japan. Based on the potential of the current market, the panorama of Asia paracetamol can be drawn out.
In this report, What are the latest production situation in AP and the consumption details of PAP and paracetamol? What is the market change of PAP and paracetamol in 2006-2010? How is the future development of PAP and paracetamol in 2011-2015? All these aspects can be found in this report. In addition, relevant policies and regulations are also covered in this report. This report combines CCM International's expertise in PAP and paracetamol market research.
Key sections of this report:
China and India, two largest API producers in the world, supply 80% of the global paracetamol market in 2010, leading Asia to be the largest origin of paracetamol. Meanwhile, the huge population makes it the largest consumption market of the world. Asia consumes 65,400 tonnes of paracetamol—half of the global output of 2010, though part of that is exported in the form of formulation. As the economy develops, Asia market will be more important.
We study the six most populous countries of AP including China, India, Indonesia, Bangladesh, Pakistan and Japan. Based on the potential of the current market, the panorama of Asia paracetamol can be drawn out.
In this report, What are the latest production situation in AP and the consumption details of PAP and paracetamol? What is the market change of PAP and paracetamol in 2006-2010? How is the future development of PAP and paracetamol in 2011-2015? All these aspects can be found in this report. In addition, relevant policies and regulations are also covered in this report. This report combines CCM International's expertise in PAP and paracetamol market research.
Key sections of this report:
- PAP production situation in China, 2008-2010
- Import and export situation of PAP in China, 2000-2010
- Detailed description on consumption patterns and various application fields, 2010
- Forecast on PAP supply and demand of in China, 2011-2015
- The paracetamol production details in AP, 2008-2010
- Import and export situation of paracetamol in AP, 2006-2010
- Paracetamol consumption pattern in AP, 2009-2010
- Forecast on paracetamol supply and demand of in China, 2011-2015
- The details of the production, IE and consumption of Chinese PAP
- The influence of Chinese PAP on paracetamol in AP
- The production, IE and consumption situation of targeted AP countries
- The strengths and weaknesses of different regional producers in AP
- The investment environment of paracetamol in AP
- The challenge and opportunity in the AP paracetamol market
Contents
EXECUTIVE SUMMARYMETHODOLOGY
1 MARKET ENVIRONMENT OF MAJOR ASIA PACIFIC COUNTRIES
1.1 General situation
1.2 Economic situation
1.3 Population & age distribution
2 PAP AND PARACETAMOL MARKET IN THE WORLD
2.1 PAP and paracetamol supply in the world
2.2 PAP and paracetamol demand in the world
3 PARACETAMOL AND PAP MARKET IN ASIA PACIFIC
3.1 PAP production in major Asia Pacific countries
3.1.1 Overview of PAP supply and demand in Asia Pacific
3.1.2 PAP market in China
3.1.2.1 China’s PAP production situation, 2006-2010
3.1.2.2 Key producers in 2011
3.1.2.3 Technology development
3.1.2.4 Trade situation of PAP in 2010
3.1.2.5 PAP consumption in China in 2010
3.1.2.6 Future forecast on PAP supply and demand in China, 2011-2015
3.2 Paracetamol market in major Asia Pacific countries
3.2.1 Overview of paracetamol supply and demand in Asia Pacific
3.2.2 China
3.2.2.1 Key policies and regulations
3.2.2.2 Production situation, 2006-2010
3.2.2.3 Major producers in 2011
3.2.2.4 Trade situation of paracetamol in 2010
3.2.2.5 Consumption situation of paracetamol in 2010
3.2.2.6 Future forecast on supply and demand, 2011-2015
3.2.3 India
3.2.3.1 Key policies and regulations
3.2.3.2 Production situation, 2007-2010
3.2.3.3 Major producers in 2011
3.2.3.4 Trade situation of paracetamol in 2010
3.2.3.5 Consumption situation of paracetamol in 2010
3.2.3.6 Future forecast on supply and demand, 2011-2015
3.2.4 Bangladesh
3.2.4.1 Key policies and regulations
3.2.4.2 Production situation, 2006-2010
3.2.4.3 Major producers in 2011
3.2.4.4 Trade situation of paracetamol in 2010
3.2.4.5 Consumption situation of paracetamol in 2010
3.2.4.6 Future forecast on supply and demand, 2011-2015
3.2.5 Indonesia
3.2.5.1 Key policies and regulations
3.2.5.2 Production situation
3.2.5.3 Trade situation of paracetamol in 2010
3.2.5.4 Consumption situation of paracetamol in 2010
3.2.5.5 Future forecast on supply and demand, 2011-2015
3.2.6 Others
3.2.6.1 Japan
3.2.6.2 Pakistan
4 CONCLUSIONS AND SUGGESTIONS
5 COMPANY PROFILES
5.1 Shandong Anqiu Lu’an Pharmaceutical Co., Ltd.
5.2 Zhejiang Conler Pharmaceutical Corporation., Ltd.
5.3 Hebei Jiheng (Group) Pharmacy Co., Ltd.
5.4 Jiangsu Wuxi Rhodia Pharmaceutical Co., Ltd.
5.5 Jiangsu Changshu Huagang Pharmaceutical Co., Ltd.
5.6 Askari Pharmaceuticals Co., Ltd.
5.7 Beximco Pharmaceuticals Ltd.
5.8 Square Pharmaceuticals Ltd.
5.9 Pan Drugs Limited.
5.10 Granules India Limited.
5.11 Globus Pharmachem Group
LIST OF TABLES
Table 3.1.2.1-1 PAP production situation in China, 2006-2010
Table 3.1.2.2-1 List of active PAP producers in China, 2011
Table 3.1.2.2-2 Capacity and output of Chinese PAP producers, 2008-2010
Table 3.1.2.3-1 Introduction to PAP production technologies in China, 2011
Table 3.1.2.3-2 Production situation of Chinese PAP producers in 2010
Table 3.1.2.3-3 PAP capacity structure by different technologies in China, 2008-2010
Table 3.1.2.4-1 Export situation of PAP in China, 2000-2010
Table 3.1.2.4-2 Export volume and price of PAP, 2010
Table 3.1.2.4-3 Export destinations of Chinese PAP, 2010
Table 3.1.2.4-4 Export situation of Chinese producers of PAP, 2010
Table 3.1.2.5-1 Production & consumption of PAP in China in 1993-2010
Table 3.1.2.5-2 The output and export of paracetamol, 2008-2010
Table 3.1.2.6-1 Assumptions of the future GDP growth in China, 2011-2015
Table 3.1.2.6-2 Factors influencing PAP development
Table 3.1.2.6-3 Historical growth rate of PAP output in China, 2006-2010
Table 3.2.1-1 Paracetamol production situation in AP, 2009-2010
Table 3.2.1-2 Paracetamol trade and consumption in AP, 2009-2010
Table 3.2.2.1-1 Regulations on paracetamol and its related products, 1996-2011
Table 3.2.2.3-1 Capacity and output of Chinese paracetamol producers, 2008-2010
Table 3.2.2.4-1 Export situation of Chinese paracetamol, 2000-2010
Table 3.2.2.4-2 Export destination and volume of Chinese paracetamol, 2001-2010, tonnes
Table 3.2.2.5-1 Production & consumption of paracetamol in China, 2000-2010
Table 3.2.2.5-2 The market value of paracetamol in China, 2006-2010
Table 3.2.2.5-3 List of some major paracetamol-containing preparations in China in 2010
Table 3.2.2.6-1 Forecast on output of China's paracetamol, 2011-2015
Table 3.2.2.6-2 Forecast on export of China's paracetamol, 2011-2015
Table 3.2.2.6-3 Forecast on domestic consumption of China's paracetamol, 2011-2015
Table 3.2.3.3-1 Capacity and output of Indian paracetamol producers, 2009-2010
Table 3.2.3.4-1 Export situation of Indian paracetamol, 2006-2010
Table 3.2.3.5-1 Paracetamol consumption situation in India, 2007-2010, tonnes
Table 3.2.3.5-2 List of some major paracetamol-containing preparations in India, 2011
Table 3.2.3.6-1 Forecast on output of Indian paracetamol, 2011-2015
Table 3.2.3.6-2 Forecast on export of Indian paracetamol, 2011-2015
Table 3.2.3.6-3 Forecast on Indian import of paracetamol from China, 2011-2015
Table 3.2.3.6-4 Forecast on domestic consumption of Indian paracetamol, 2011-2015
Table 3.2.4.2-1 Paracetamol production in Bangaldesh, 2006-2010
Table 3.2.4.3-1 Paracetamol prodcution information in Bangladesh, 2009-2010
Table 3.2.4.4-1 Bangladesh PAP import situation from China, 2005-2010
Table 3.2.4.4-2 Bangladesh paracetamol import situation from China, 2006-2010
Table 3.2.4.5-1 Bangladesh paracetamol apparent consumption, 2009-2010
Table 3.2.4.5-2 List of some major paracetamol-containing preparations in Bangladesh, 2011
Table 3.2.5.2-1 Paracetamol production in Indonesia, 2006-2010
Table 3.2.5.3-1 Indonesia's PAP import situation from China, 2005-2010
Table 3.2.5.3-2 Indonesia's paracetamol import situation from China, 2006-2010
Table 3.2.5.4-1 Total Import volume of paracetamol in Indonesia, 2009-2010, tonnes
Table 3.2.5.4-2 Indonesia's apparent consumption of paracetamol, 2009-2010
Table 3.2.5.4-3 List of some major paracetamol-containing preparations in Indonesia, 2011
Table 3.2.6.1-1 Japan's paracetamol import situation from India and China, 2010
Table 3.2.6.1-2 List of some major paracetamol-containing preparations in Japan, 2011
Table 3.2.6.2-1 Capacity and output of paracetamol in Pakistan, 2008-2010, tonnes
Table 3.2.6.2-2 Pakistan PAP import situation from China, 2008-2010
Table 3.2.6.2-3 Pakistan paracetamol import situation from China, 2005-2010
Table 5.1-1 Production and price of paracetamol in Shandong Lu'an,2009-2011
....
Table 5.11-1 Production and price of paracetamol in Globus Pharmachem, 2009-2011
LIST OF FIGURES
Figure 2.1-1 The output of PAP in the world, 2006-2010
Figure 2.1-2 The output of paracetamol in the world, 2006-2010
Figure 2.1-3 Paracetamol production distribution by output volume in the world, 2010
Figure 2.2-1 PAP consumption pattern in the world, 2010
Figure 2.2-2 PAP consumption pattern in China, 2010
Figure 2.2-3 The paracetamol consumption in the world, 2010
Figure 3.1.2.4-1 Export volume and price comparison of PAP produced by two different technologies in China, 2000-2010
Figure 3.1.2.6-1 China's GDP growth, 2006-2010
Figure 3.1.2.6-2 Forecast on output of China's PAP, 2011-2015
Figure 3.1.2.6-3 Forecast on domestic consumption of China's PAP, 2011-2015
Figure 3.1.2.6-4 Forecast on export of China's PAP, 2011-2015
Figure 3.2.2.2-1 Capacity and output of Chinese paracetamol, 2005-2010
Figure 3.2.2.2-2 Geographical distribution of active paracetamol producers in China, 2011
Figure 3.2.2.4-1 Changes in top 7 export destinations of Chinese paracetamol, 2008-2010, tonnes
Figure 3.2.3.2-1 Capacity and output of Indian paracetamol, 2007-2010
Figure 3.2.4.6-1 Forecast on output of Bangladesh's paracetamol, 2011-2015
Figure 3.2.4.6-2 Forecast on Bangladesh's import of paracetamol from China, 2011-2015
Figure 3.2.4.6-3 Forecast on domestic consumption of Indonesian paracetamol, 2011-2015
Figure 3.2.5.5-1 Forecast on domestic consumption of Indonesian paracetamol, 2011-2015
Figure 3.2.5.5-2 Forecast on Indonesian import of paracetamol from China, 2011-20
COMPANIES MENTIONED
Liaoning Shixing Pharmaceutical & Chemical Co., Ltd.
Jiangsu Zhongming Pharm-Chemical Co., Ltd.
Hebei Jiheng (Group) Pharmacy Co., Ltd.
Jiangsu Wuxi Rhodia Pharmaceutical Co., Ltd.
Granules India Limited. Skip to top